{"cdcTestId":"2013-0495","testcaseName":"#2 with interval of 5 years of #1","vaccineGroup":"MCV","evaluationTestType":"Interval: At Recommended","forecastTestType":"Not recommended: series complete","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2004-10-19T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2017-10-19T00:00:00","vaccineName":"MENACTRA","cvx":"114","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"MENACTRA","cvx":"114","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"-","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2017-10-19T00:00:00","vaccineName":"MENACTRA","cvx":"114","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"MENACTRA","cvx":"114","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-06-01T12:06:39.543","generalDescription":"This test case describes when dose #2 of a Mening vaccine is administered 5 years after dose #1 (age 13), that the dose in considered valid. The series is complete.","changedInVersion":"1.2","reasonForChange":"Test case was set to have the first dose at age 16 and second dose at 21 years.  Test case was adjusted to be at 13 years and 18 years to avoid the 16 year age skip dose which is tested in another test"}